Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study.
Saved in:
| Title: | Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study. |
|---|---|
| Authors: | Pérez-Belmonte, Luis M.1 (AUTHOR) luismiguelpb1984@gmail.com, Torres-Peña, José David2,3 (AUTHOR), López-Carmona, María D.1 (AUTHOR), Ayala-Gutiérrez, M. Mar.1 (AUTHOR), Fuentes-Jiménez, Francisco2,3 (AUTHOR), Huerta, Lucía Jorge4 (AUTHOR), Muñoz, Jaime Alonso5 (AUTHOR), Rubio-Rivas, Manuel6 (AUTHOR), Madrazo, Manel7 (AUTHOR), Garcia, Marcos Guzmán8 (AUTHOR), Montes, Beatriz Vicente9 (AUTHOR), Sola, Joaquim Fernández10 (AUTHOR), Ena, Javier11 (AUTHOR), Ferrer, Ruth Gonzalez12 (AUTHOR), Pérez, Carmen Mella13 (AUTHOR), Ripper, Carlos Jorge14 (AUTHOR), Lecumberri, Jose Javier Napal15 (AUTHOR), Acedo, Iris El Attar16 (AUTHOR), Canteli, Susana Plaza17 (AUTHOR), Cosío, Sara Fuente18 (AUTHOR) |
| Source: | BMC Medicine. 11/16/2020, Vol. 18 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17417015 |
|---|---|
| DOI: | 10.1186/s12916-020-01832-2 |
